In response to TNF-α, interleukin (IL)-6, and IL-1β stimulation, Th22 cells expressing CCR4, CCR6, and CCR10 migrate to the synovial tissues of patients with active RA and produce IL-22 to stimulate osteoclast differentiation for bone destruction (60). Here, CCR10 is linked to rheumatoid arthritis.